Login / Signup

Editorial Comment from Dr Kobayashi to Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.

Takashi Kobayashi
Published in: International journal of urology : official journal of the Japanese Urological Association (2022)
Keyphrases
  • editorial comment
  • sars cov
  • renal cell carcinoma
  • respiratory syndrome coronavirus
  • high grade
  • urinary tract
  • mesenchymal stem cells
  • cell therapy